Popular Articles

Novartis Successfully Demonstrates Capabilities Of Cell-based Technology For Production Of A(H1N1) Vaccine
Novartis has successfully completed the production of the first batch of influenza A(H1N1) vaccine, weeks ahead of expectations. Cell-based manufacturing technology[1] allows vaccine production to be initiated once a pandemic virus strain is identified without the need to adapt the virus strain to grow in eggs, as with traditional vaccine technologies. This advance has cut weeks off the time required to begin vaccine production. This first batch of ten liters of wild type influenza A(H1N1) vaccine monobulk will be used for pre-clinical evaluation and testing and is also being considered for use in clinical trials. It demonstrates the value of the cell-based production approach, that is also being used by Novartis with reassortant influenza A(H1N1) seed.
generic viagra online
Faculty Of Translational Medicine Boosts Support For Biomedical Researchers
A new Faculty of Translational Medicine has been launched to increase support for, and enhance collaboration among researchers as they search for new treatments and diagnostic tests for a range of diseases and conditions. The Faculty is based in the National Institute for Health Research Comprehensive Biomedical Research Center at Guy"s and St Thomas" hospitals and King"s College London.
News of the day
Johns Hopkins Neuroscientists Watch Memories Form In Real Time
Our ability to form long-term memories depends on cells in the brain making strong connections with each other. Yet while it"s not well understood how those connections are made, lost or changed, the process is known to involve the movement of the AMPA receptor protein to and from those neuronal connections.
Diagnostics

British Veterinary AssociationGuide To Partnerships In Veterinary Practice, UK

Continuing efforts to help its members form lasting and profitable partnerships and pre-empt disputes in veterinary practice, the British Veterinary Association (BVA) has revised its "Guide to partnerships in veterinary practice". It will be of particular interest to vets buying into a partnership for the first time and will also be helpful to partners revising their existing agreement. The lack of a formal agreement between veterinary practice partners could have detrimental consequences for everyone concerned. This guide therefore aims to draw attention to the areas which should be included as part of an agreement between partners to help reduce misunderstandings at a later date. Available to download, the Guide includes sections on - decision making and authority - profits and losses - salaried partners - good faith - capital assets - insurance - tax and accounts - dissolution - outgoing partners" undrawn profits and capital - death - power of attorney - disputes and arbitration - and more Launching the Guide, Andrew Parker, chair of the BVA Members" Services Group, said "I think this is an example of the hard work and commitment that the BVA is making to its members. It is a very good starting point with good advice for someone embarking on a major change in their working life." The Guide is available for BVA members to download. British Veterinary Association


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):